Corey Davis, director of the Harm Reduction Legal Project at the Network for Public Health Law, discusses the challenges of improving naloxone distribution; Carolyn Mullen, ASTHO senior vice president of government affairs …
Dr. Manisha Juthani, commissioner of the Connecticut Department of Public Health, spent her week in Washington, D.C., discussing the importance of the Public Health Infrastructure Grant to her state; Arthur San Agustin, spec…
Kayley Humm, ASTHO Senior Analyst, discusses a new ASTHO report that outlines a series of overdose prevention policies for consideration by public health agencies; Sarah Bonk, Mental Health Disaster and Emergency Response Co…
Brianna Gorman, ASTHO analyst for Performance Excellence, explains ways to connect public health and health care in communities; Dr. Lindsay Weaver, ASTHO member and state health commissioner for the Indiana Department of He…
Dr. Sameer Vohra, ASTHO member and director of the Illinois Department of Public Health, tells us new laws in Illinois will seek to address the deadly effects of fentanyl; Paul Schramm, health scientist for the CDC, details …
Dr. Anne Zink, ASTHO immediate past president and chief medical officer for the Alaska Department of Health, says policies can help address the fact that the number of babies born with syphilis is ten times higher than in 20…
Dr. Steven Stack, ASTHO president and commissioner of public health for the Commonwealth of Kentucky, discusses substance misuse and overdose prevention strategies; Dr. Susan Kansagra, North Carolina Department of Health and…
Dr. Lauren Tanz, an epidemiologist with the CDC, talks about the rising numbers of teen overdose deaths in the United States; Dr. Dylan George, director of the Center for Forecasting and Outbreak Analytics at the CDC, discus…
Dr. Rahul Gupta, Director of National Drug Control Policy at the White House, outlines the federal government’s response to the threat of Xylazine; the 2024 Diverse Executives Leading in Public Health (DELPH) Program is acce…
